News AVEO Pharmaceuticals, Inc. Börse Stuttgart

Equities

VPA

US0535881090

Delayed Börse Stuttgart Other stock markets 10:33:53 2021-10-05 EDT			5-day change	1st Jan Change
5.28 ^EUR	-0.19%		-10.02%	+20.93%

03-25	AVEO Pharmaceuticals, Inc. Announces Executive Changes	CI
02-06	Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AVEO Pharmaceuticals, Inc. Announces Executive Changes	03-25	CI
Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist	02-06	CI
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)	01-16	CI
AVEO Oncology Announces Completion of Enrollment in Pivotal Phase 3 TiNivo-2 Study of FOTIVDA(R) in Combination with OPDIVO(R) in Advanced Renal Cell Carcinoma	23-06-27	CI
South Korean Stocks Climb on Demand Recovery Hopes from China; LG Chem Stocks Add 1%	23-01-20	MT
AVEO Completes Acquisition by LG Chem	23-01-20	MT
LG Chem Acquires US Biopharma Firm AVEO Pharmaceuticals	23-01-19	MT
AVEO PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	23-01-19	AQ
LG Chem Completes Acquisition of AVEO Oncology	23-01-19	GL
AVEO Pharmaceuticals, Inc. Announces Management Changes	23-01-19	CI
AVEO Oncology Appoints Martin Birkhofer as Its Chief Medical Officer	23-01-19	CI
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from NASDAQ Composite Index	23-01-19	CI
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from S&P Global BMI Index	23-01-19	CI
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from S&P TMI Index	23-01-19	CI
LG Chem, Ltd. completed the acquisition of AVEO Pharmaceuticals, Inc. from a group of shareholders.	23-01-18	CI
AVEO Pharmaceuticals Receives CFIUS Clearance for LG Chem Merger	23-01-18	MT
AVEO Pharmaceuticals : Merger Agreement - Form 8-K	23-01-18	PU
AVEO PHARMACEUTICALS, INC. : Other Events (form 8-K)	23-01-18	AQ
AVEO Pharmaceuticals Stockholders Approve LG Chem Merger	23-01-06	MT
AVEO Oncology Stockholders Approve Acquisition by LG Chem	23-01-05	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AVEO Pharmaceuticals, Inc. Börse Stuttgart

Equities

VPA

US0535881090

Summary

Filters